RORY B RIGGS
CIK 1016835 · Chief Executive Officer · last filed 2026-06-04
RORY B RIGGS is a Chief Executive Officer who has filed 119 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for CBUS, was dated Jun 4, 2026. Across all open-market trades the lifetime net is −$221.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $40.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$40.61M
4
119
-$221.94M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CBUS | Director | 14,940,447 | $1.23 | $18.38M | $5.47M | 12 | 2026-06-04 |
| Intra-Cellular Therapies, Inc. (ITCI) Delisted | Director | 0 | $131.87 | $0 | -$12.95M | 64 | 2025-04-02 |
| RPRX | Director | 405,286 | $54.87 | $22.24M | -$208.34M | 27 | 2024-02-22 |
| KYNTRA BIO, INC. (FGEN) Delisted | Director | 1,001,463 | $9.75 | $9.76M | -$6.13M | 15 | 2021-05-28 |
Recent Filings
119 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | CBUS | Grant (A) | — | $0 | EDGAR |
| 2026-02-02 | CBUS | Grant (A) | +333,333 | $500.0K | EDGAR |
| 2025-06-11 | CBUS | Exer (X) | +4,050,000 | $900 | EDGAR |
| 2025-06-10 | CBUS | Grant (A) | +5,714,286 | $10.00M | EDGAR |
| 2025-05-27 | CBUS | Grant (A) | — | $0 | EDGAR |
| 2025-04-02 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Disp (D) | −131,512 | -$17.36M | EDGAR |
| 2025-01-23 | CBUS | Grant (A) | — | $0 | EDGAR |
| 2025-01-10 | CBUS | Conv (C) | — | $0 | EDGAR |
| 2025-01-03 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +215 | $18.0K | EDGAR |
| 2024-10-15 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Exer (M) | +14,189 | $0 | EDGAR |